WHO Prequalifies First Ever Malaria Treatment for Newborns and Infants – Asrar Qureshi’s Blog Post #1259
WHO Prequalifies First Ever Malaria Treatment for Newborns and Infants – Asrar Qureshi’s Blog Post #1259 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1259 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Preamble The WHO prequalified Coartem Baby in April 2026 as a malaria treatment designed for infants weighing 2–5 kg (4.4–11 lb). These sweet cherry-flavored, dissolvable tablets treat acute, uncomplicated malaria, addressing a gap in neonatal care. The drug has been developed by Novartis and Medicines for Malaria Venture and is designed for distribution in high-risk areas. The drug contains artemether and lumefantrine. The combination is not new as such; it has been in use for children and adults for many years. However, the use in newborns and infants was not qualified and relevant dosage forms were no...